Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Allopurinol-induced recurrent dress syndrome: Pathophysiology and treatment 5. Debunking Myths in the US Healthcare System
Top Ten Searches
aldosteronism contrast dialysis vitamin d bicarbonate arf amyloidosis hypocalcemia renal artery husYour Article Summary
See Latest ArticlesCoronary heart disease benefits from blood pressure and lipid-lowering
International Journal of Cardiology, 06/15/09
Sever PS et al. – Coronary heart disease (CHD) benefits associated with blood pressure (BP) and lipid lowering were larger than predicted by previous observational and trial data. Compared with pre-trial treatment, treating an estimated 55 pts with the amlodipine-based regimen and atorvastatin would prevent 1 CHD event per year.
Methods- Report of analyses on combined benefits of atorvastatin and an amlodipine-based regimen for CHD events in hypertensive pts in Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)
- Randomization of 19,342 hypertensive pts to either an amlodipine or atenolol-based regimen in ASCOT Blood Pressure-Lowering Arm (BPLA)
- Further randomization 10,305 subjects with total cholesterol ≤6.5 mmol/L to atorvastatin 10 mg or placebo in Lipid-Lowering Arm (LLA)
- Estimates of CHD risk at baseline based on Framingham algorithm compared with observed and predicted event rates throughout ASCOT-LLA
- Estimated baseline Framingham risk of CHD events: 22.8 / 1000 pt yrs
- After 3.3 yrs, when LLA stopped, actual CHD event rate was 4.8 / 1000 pt years -- 79% reduction in pts assigned amlodipine-based treatment and atorvastatin
Related Articles
Aggressive lipid-lowering is more effective than moderate lipid-lowering treatment in carotid plaque stabilization
Journal of Vascular Surgery, 10/21/09
Relevance Score: 84%
Total cholesterol and LDL levels decrease before rheumatoid arthritis
Annals of Rheumatic Diseases, 11/10/09
Relevance Score: 82%
Lipid-Lowering Therapy for the Primary Prevention of Cardiovascular Disease in the Elderly: Opportunities and Challenges
Drugs & Aging, 10/26/09
Relevance Score: 80%
Positive change in the utilization of antihypertensive and lipid-lowering drugs among adult diabetics in Finland. Results from large national database between 2000 and 2006
Journal of Hypertension, 10/23/09
Relevance Score: 80%
ADAM17_i33708A>G polymorphism interacts with dietary n-6 polyunsaturated fatty acids to modulate obesity risk in the Genetics of Lipid Lowering Drugs and Diet Network study
Nutrition, Metabolism & Cardiovascular Diseases, 10/15/09
Relevance Score: 80%
Today in Hypertension...keeping you current
Receive free subspecialty "5-minute updates" via email
Prehypertension in Outpatient Obese Children
American Journal of Hypertension, 12/01/09
Comparison of Risk Factors Associated With Hypertension Subtypes by Classification Tree Method in Tongshan County of Jiangsu Province, China
American Journal of Hypertension, 12/01/09
Association Between Insurance Gaps and Continued Antihypertension Medication Usage in a US National Representative Population
American Journal of Hypertension, 12/01/09
Article Search
Sponsor